About Well Worth Life Sciences Private Limited
Data last updated:
Well Worth Life Sciences Private Limited is a private limited company based in Chennai, Tamil Nadu, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 13 March 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U51909TN2014PTC095430. Its GSTIN is 33AABCW5040J1ZH (Tamil Nadu).
The company has an authorised share capital of ₹2 Lakh and a paid-up capital of ₹2 Lakh. It is led by directors Mohamed Yasar Arafath and Anwar Ali Fathima Safrin.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at New No.1103 Old No.371 T.H Road Old Washermenpet, Chennai, Tamil Nadu, India – 600021.
As per the financials filed for FY 2024, the company reported a revenue of ₹25.01 Lakh, a decline of 19% compared to the previous year. For the same year it recorded a net loss of ₹4.97 Lakh (net margin -19.9%) and EBITDA of -₹4.75 Lakh (EBITDA margin -19%). Revenue has declined at a compounded annual rate (CAGR) of 9% over three years and 3% over five years.
The current compliance status is marked as active non-compliant by the Registrar of Companies. For more details, the company can be reached via its website petwell.in.
Company details
Contact details
Well Worth Life Sciences Private Limited's registered office is in Chennai, Tamil Nadu. Its website is petwell.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressNew No.1103 Old No.371 T.H Road Old Washermenpet, Chennai, Tamil Nadu, India – 600021
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Well Worth Life Sciences Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Well Worth Life Sciences is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Well Worth Life Sciences Private Limited, buy the company report.
Financials of Well Worth Life Sciences Private Limited
FY 2024 filings availableWell Worth Life Sciences Private Limited reported revenue of ₹25.01 Lakh (down 19% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 3% over five years, including a 19% fall in the latest year. EBITDA fell 824% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹4.75 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹4.97 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -19% | ||||
| Net Profit Margin | -19.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Well Worth Life Sciences Private Limited, buy the company report.
Board of directors of Well Worth Life Sciences Private Limited
Well Worth Life Sciences has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mohamed Yasar Arafath | Director | 13 Mar 2014 | 12 Years 7 Months | Current |
| Anwar Ali Fathima Safrin | Director | 04 May 2023 | 3 Years 5 Months | Current |
Shareholding
The shareholding of Well Worth Life Sciences Private Limited is on record for FY 2018, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2018 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Public | |
| Others |
To see the full shareholding pattern of Well Worth Life Sciences Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Well Worth Life Sciences Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Well Worth Life Sciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Well Worth Life Sciences has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 33AABCW5040J1ZH | Tamil Nadu | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Well Worth Life Sciences Private Limited, buy the company report.
Recent activity
Well Worth Life Sciences Private Limited has 3 board changes on record since 2014: 2 appointments and 1 cessation. The latest: Anwar Ali Fathima Safrin was appointed as Director on 04 May 2023.
Frequently asked questions
Well Worth Life Sciences is an active private limited company based in Chennai, Tamil Nadu, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 13 March 2014 (12+ years old) and is registered under CIN U51909TN2014PTC095430.
Well Worth Life Sciences has 2 current directors:
- Mohamed Yasar Arafath - Director
- Anwar Ali Fathima Safrin - Director
The latest financial statements of Well Worth Life Sciences on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Well Worth Life Sciences is 33AABCW5040J1ZH, registered in Tamil Nadu.
The CIN (Corporate Identification Number) of Well Worth Life Sciences is U51909TN2014PTC095430. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Well Worth Life Sciences was incorporated on 13 March 2014, making it 12+ years old. It is registered with the Registrar of Companies, Chennai.
Anwar Ali Fathima Safrin was appointed as Director on 04 May 2023. Shameer Mohamed Kadathur Thaha ceased to be Director on 04 May 2023. Mohamed Yasar Arafath was appointed as Director on 13 Mar 2014.
Well Worth Life Sciences can be reached through the website petwell.in. Its registered office is in Chennai, Tamil Nadu, India.
The registered office of Well Worth Life Sciences is at New No.1103 Old No.371 T.H Road Old Washermenpet, Chennai, Tamil Nadu, India – 600021.
Well Worth Life Sciences operates in the pharma industry, in the drug formulation and development segment.